BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit

FRANKLIN LAKES, N.J., Jan. 12, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Pre... Devices, FDA BD , Vacutainer, blood collection tube
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news